Jean-Luc Butel

Jean-Luc Butel possesses extensive experience in corporate governance and advisory roles across various sectors, particularly in healthcare and technology. Currently serving as a Board Member and Chair of the Nominating and Corporate Governance Committee at Rani Therapeutics, Jean-Luc also contributes to Novo A/S as a member of the Advisory Group and Board. Additional board memberships include Takeda Pharmaceuticals, K8 Global Pte. Ltd., and Varian Medical Systems, where Jean-Luc has held key positions in committees focused on nomination, audit, and compensation. Prior involvement includes roles at SGInnovate, A*ccelerate, BioMers Pte Ltd, and the Singapore Economic Development Board. Educational qualifications include an MBA in International Business from the American Graduate School of International Management and a BA in International Relations and Economics from The George Washington University.